What is Driving a Strong Bullish Sentiment Towards Viking Therapeutics (VKTX) [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Back on March 26, Viking Therapeutics Inc. (NASDAQ:VKTX) reported the final recruitment of patients into the Phase 3 VANQUISH-2 study of its investigational subcutaneous drug VK2735, a dual agonist of the GLP-1 and GIP receptors. The drug is being studied for oral and subcutaneous administration in the treatment of various metabolic diseases. Sergey Nivens/Shutterstock.com Furthermore, Viking is performing the Phase 3 VANQUISH-1 trial of VK2735 administered subcutaneously to patients for the treatment of obesity or being overweight. The enrollment for the VANQUISH-1 trial was completed in November 2025. Additionally, Viking is performing a Phase 1 trial assessing multiple maintenance dosing strategies for VK2735. The primary goals of the trial involve assessing the safety, tolerability, and pharmacokinetics of VK2735 administered under various dosing schemes. Secondary goals measure the body weight changes from the baseline and after the switch to maintenance dosing. The result
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics (VKTX) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street [Yahoo! Finance]Yahoo! Finance
- This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026PR Newswire
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- VKTX's page on the SEC website